Indole derivative and medical application thereof
A kind of indole and pharmaceutical technology, applied in the field of biomedicine, can solve problems such as cardiotoxicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0122] 6-Chloro-3-(diethylamino)-5-fluoro-1-phenyl-1H-indole-2-carboxylic acid (Compound 1)
[0123]
[0124]
[0125] Get compound I-1 (20g, 137mmol) and place in round-bottomed flask (1L), add water (411mL) and concentrated hydrochloric acid (137mL), under ice bath slowly add dropwise the aqueous solution of sodium nitrite (10.4g, 151mmol) ( 82mL), after adding, continue stirring under ice bath for 45 minutes, add the concentrated hydrochloric acid solution (68.5mL) of stannous chloride dihydrate (61.8g, 274mmol) in the reaction solution, a large amount of solids are separated out, add, slowly Rising to room temperature, the reaction solution was suction-filtered, the filter cake was washed successively with saturated brine (50mL×2) and diethyl ether (50mL×2), and dried in vacuo to obtain compound I-2 (red-brown solid, 24.2g, yield 90% ): 1 H NMR (300MHz, DMSO-d 6 )δ10.53(s,3H),8.57(s,1H),7.43-7.21(m,2H),7.14-6.96(m,1H).
[0126] Compound I-2 (24.2g, 123mmol) was su...
Embodiment 2
[0133] 4-Chloro-3-(diethylamino)-5-fluoro-1-phenyl-1H-indole-2-carboxylic acid (compound 2)
[0134]
[0135] Suspend compound I-9 (715mg, 2.15mmol) and potassium carbonate (594mg, 4.30mmol) in acetonitrile (1mL), add iodoethane (1.02mL, 17.18mmol) to the reaction solution, seal the tube and heat and stir at 100°C 24 hours. After the reaction of the raw materials was completed, the heating was stopped, cooled to room temperature, the solvent was evaporated under reduced pressure, and the residue was purified by column chromatography (petroleum ether: ethyl acetate = 100:1) to obtain compound II-1 (yellow oily liquid, 760mg , yield 91%): 1 H NMR (300MHz, CDCl 3 )δ7.52-7.39(m,3H),7.33-7.28(m,2H),7.17(dd,J=8.8,6.8Hz,1H),6.86(d,J=8.8Hz,1H),4.13(q ,J=7.1Hz,2H),3.23-3.14(m,4H),1.09-0.99(m,9H).
[0136] Compound II-1 (100mg, 2.95mmol) was dissolved in a mixed solution of methanol and tetrahydrofuran (4.5mL, v:v=1:2), and aqueous potassium hydroxide solution (1.5mL, 1.5mmol) wa...
Embodiment 3
[0138] 3-(Diethylamino)-5-fluoro-1-phenyl-1H-indole-2-carboxylic acid (Compound 3)
[0139]
[0140] Compound 3 was obtained by referring to the method of Example 1: 1 H NMR (300MHz, DMSO-d 6 )δ16.12(s,1H),7.88-7.80(m,1H),7.60-7.47(m,3H),7.44-7.36(m,2H),7.27-7.17(m,1H),7.14-7.06( m, 1H), 3.44(q, J=7.2Hz, 4H), 1.04(t, J=7.2Hz, 6H).ESI-MS: m / z 349.1[M+Na] + .
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


